Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
暂无分享,去创建一个
K. Huber | S. Farhan | J. Wojta | K. Krychtiuk | S. Demyanets | W. Speidl | T. Weiss | A. Wonnerth | K. Katsaros | R. Járai | Ioannis Tentzeris